References
- Altman , N. 1985 . Pathology of Laboratory Mice and Rats , Bethesda, Md. : Pergamon Infoline, Inc. .
- Baum , J. K. , Bookstein , J. J. , Holtz , F. and Klein , E. W. 1973 . Possible association between benign hepatomas and oral contraceptives . Lancet , 2 : 926 – 929 .
- Berenblum , I. 1941 . The cocarcinogenic action of croton resin . Cancer Res. , 1 : 44 – 48 .
- Blank , M. S. , Ching , M. C. and Dufau , M. L. 1986 . Bioactivity of serum and pituitary prolactin during the rat estrous cycle . Endocrinology , 118 : 1886 – 1891 .
- Buckley , A. R. , Putnam , C. W. and Russell , D. H. 1984 . Rapid elevation of plasminogen activator activity in rat tissue by prolactin . Biochem. Biophys. Res. Commun. , 122 (3) : 1005 – 1011 .
- Buckley , A. R. , Putnam , C. W. and Russell , D H. 1985 . Prolactin is a tumor promoter in rat liver . Life Sci. , 37 : 2569 – 2575 .
- Buckley , A. R. , Putnam , C. W. , Montgomery , D. W. and Russell , D. H. 1986 . Prolactin administration stimulates rat hepatic DNA synthesis . Biochem. Biophys. Res. Commun. , 138 : 1138 – 1145 .
- Butcher , R. I. , Fugo , N. W. and Collins , W E. 1972 . Semicircadian rhythm in plasma levels of prolactin during early gestation in the rat . Endocrinology , 90 : 1125 – 1127 .
- Cameron , R. , Imaida , K. and Ito , N. 1981 . Promotive effects of ethinyl estradiol in hepatocarcinogenesis initiated by diethylnitrosamine in male rats . Gann , 72 : 339 – 340 .
- Campen , D. B. , Nelson , K. G. , Maronpot , R. R. and Lucier , G. W. 1987a . Localization of exogenously administered 3H‐ethynylestradiol in the rat two‐stage model of hepatocarcinogenesis . Toxicologist , 7 : 106
- Campen , D. B. , Sloop , T. C. , Maronpot , R. R. and Lucier , G. W. 1987b . Continued development of hepatic gamma‐glutamyltranspeptidase‐positive foci upon withdrawal of 17α‐ethinylestradiol in diethylnitrosamine‐initiated rats . Cancer Res. , 47 : 2328 – 2333 .
- Chen , C. L. , Amenomori , Y. , Lu , K. H. , Voogt , J. L. and Meites , J. 1970 . Serum prolactin levels in rats with pituitary transplants or hypothalamic lesions . Neuroendocrinology , 6 (4) : 220 – 227 .
- David , R. K. , Stevenson , G. T. and Busch , K. A. 1955 . Tumor incidence in normal female Sprague‐Dawley rats . Cancer Res. , 16 : 194 – 197 .
- De Nicola , A. F. , Von Lawzewitsch , I. , Kaplan , S. E. and Ligbertun , C. 1978 . Biochemical and ultra‐structural studies on estrogen‐induced pituitary tumors in F344 rats . J. Natl. Cancer Inst. , 61 : 753 – 763 .
- Forman , D. , Doll , R. and Petro , R. 1983 . Trends in mortality from carcinoma of the liver and the use of oral contraceptives . Br. J. Cancer , 48 : 349 – 354 .
- Fotherby , F. 1982 . Pharmacokinetics of ethynylestradiol in humans Methods Find . Exp. Clin. Pharmacol. , 4 : 133 – 141 .
- Friedwald , W. and Rous , P. 1944 . The initiating and promoting elements in tumor production . J. Exp. Med. , 80 : 101 – 125 .
- Goldsworthy , T. , Campbell , H. A. and Pitot , H. C. 1984 . The natural history and dose‐response characteristics of enzyme‐altered foci in rat liver following phenobarbital and diethylnistroamine administration . Carcinogenesis , 5 (1) : 67 – 71 .
- Henderson , B. , Preston‐Martin , S. , Edmondson , H. , Peters , R. and Pike , M. 1983 . Hepatocellular carcinoma and oral contraceptives . Br. J. Cancer , 48 : 437 – 440 .
- Johnson , M. P. and Crowley , W. R. 1983 . Acute effects of estradiol on circulating luteinizing hormone and prolactin concentrations and on serotonin turnover in brain nuclei . Endocrinology , 113 : 1935 – 1941 .
- Kaufman , J. M. , Thiery , M. and Vermeulen , A. 1981 . Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives . Contraception , 24 : 589 – 602 .
- Kitagawa , T. , Hino , O. , Nomura , K. and Sugano , H. 1984 . Dose‐response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in rat hepatocarcinogenesis . Carcinogenesis , 5 (12) : 1653 – 1656 .
- Lloyd , R. V. 1983 . Estrogen‐induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study . Am. J. Pathol. , 113 : 198 – 206 .
- Maronpot , R. R. , Montgomery , C. , Boorman , G. and McConnell , E. 1986 . National Toxicology Program nomenclature for hepatoproliferative lesions of rats . Toxicol. Pathol , 14 (2) : 263 – 273 .
- Nelson , K. N. , Vickers , A. E. M. , Sunahara , G. I. and Lucier , G. W. 1987 . “ Receptor and DNA ploidy changes during promotion of rat liver carcinogenesis ” . In Tumor Promoters: Biological Approaches for Mechanistic Studies and Assay Systems , Edited by: Barrett , J. C. , Langenbach , R. and Elmore , E. 387 – 405 . New York : Raven Press .
- Office of Science and Technology Policy . 1985 . “ Chemical carcinogens; A review of the science and its associated principles ” . In Federal Register , Washington, D.C. : U.S. Printing Office .
- Pitot , H. C. and Sirica , A. E. 1980 . The stages of initiation and promotion in hepatocarcinogenesis . Biochem. Biophys. Ada , 605 : 191 – 215 .
- Pitot , H. C. , Goldsworthy , T. , Moran , W. , Kennan , W. , Glauert , H. , Maronpot , R. R. and Campbell , H. A. 1987 . A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose‐response relationships to altered hepatic foci . Carcinogenesis , 8 : 1491 – 1499 .
- Powell‐Jones , W. , Nayfeh , S. N. and Lucier , G. W. 1978 . Translocation of 4S and 5S forms of estrogen receptor into rat liver nuclei . Biochem. Biophys. Res. Commun. , 85 : 167 – 170 .
- Schulte‐Herman , R. 1985 . Tumor promotion in the liver . Arch. Toxicol. , 57 : 147 – 158 .
- Solt , D. B. , Medline , A. and Farber , E. 1977 . Rapid emergence of carcinogen‐induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis . Am. J. Pathol. , 88 : 595 – 628 .
- Tennekes , H. A. , Edler , L. and Kunz , H. W. 1982 . Dose‐response analysis of the enhancement of liver tumor formation of CF‐1 mice by dieldrin . Carcinogenesis , 3 : 941 – 945 .
- Thompson , C. , Hudson , P. M. and Lucier , G. W. 1985 . Correlation of hepatic estrogen receptor concentration and estrogen‐mediated elevation of very low density lypoproteins . Endocrinology , 112 : 1389 – 1397 .
- Wanless , I. R. and Medline , A. 1982 . Role of estrogens as promoters of hepatic neoplasia . Lab. Invest. , 46 (3) : 13 – 320 .
- Yager , J. D. and Yager , R. 1980 . Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague‐Dawley rats . Cancer Res. , 40 : 3680 – 3685 .
- Yager , J. D. , Campbell , H. A. , Longnecker , D. S. , Roebuck , B. D. and Benoit , M. C. 1984 . Enhancement of hepatocarcinogenesis in female rats by ethinyl esradiol and mestranol but not estradiol . Cancer Res. , 44 : 3862 – 3869 .
- Yager , J. D. , Roebuck , J. D. , Paluszayk , T. L. and Memoli , V. A. 1986 . Effects of ethinyl estradiol and tamoxifen on DNA turnover and new synthesis and appearance of gamma‐glutamyltranspeptidase‐positive foci in female rats . Carcinogenesis , 7 (12) : 2007 – 2014 .